What are the relative values of different outcomes for determining the efficacy and potential harms of heart failure medications in people with CKD?
The committee agreed that all-cause mortality, all-cause unplanned hospitalisation and quality of life were the most critical outcomes for determining the efficacy and potential harms of heart failure medications in people with CKD.